Physician profile
Christopher B Clemow
NPI 1093748386
$2,924.97
in general payments reported to CMS, 2019-2025
11 companies · $81.94 in 2025
The $81.94 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.70 · 2021: $2,422 · 2022: $81.48 · 2023: $105 · 2024: $221 · 2025: $81.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $2,443.54 | 2021-2024 | |
| Bioventus LLC | $174.88 | 2019-2025 | Exogen Ultrasound Bone Healing System, Durolane, Durolane |
| Ferring Pharmaceuticals INC. | $120.65 | 2023-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $59.68 | 2024 | Monovisc, Orthovisc |
| Innovation Technologies INC | $27.82 | 2025 | Irrisept |
| Astrazeneca Pharmaceuticals LP | $21.19 | 2024 | Airsupra |
| Boston Scientific Corporation | $17.15 | 2022 | |
| Abbvie INC. | $16.72 | 2024 | |
| Fidia Pharma USA INC. | $16.15 | 2024 | Hymovis, Triluron, Hyalgan |
| Abbott Laboratories | $13.63 | 2022 | |
| Hologic Sales and Service, LLC | $13.56 | 2024 | Aptima, Thinprep 2000 Processor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Clemow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.